Jeffrey B. Mirviss, EVP&Pres, Periph Intervent at BOSTON SCIENTIFIC CORP (BSX), sold 353 shares at $55.03 ($19K) on 2023-12-06, disclosed to the SEC on 2023-12-07.
Scheduled sale ($19k) by EVP&Pres, Periph Intervent under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BSX | SELL | 2025-02-13 | $2.7M | — | Filing → |
| BSX | SELL | 2025-01-03 | $1.3M | — | Filing → |
| BSX | SELL | 2024-05-30 | $9.6M | — | Filing → |